Literature DB >> 7815503

Characterization of the Epstein-Barr virus proteinase and comparison with the human cytomegalovirus proteinase.

G Donaghy1, R Jupp.   

Abstract

The BVRF2 gene of Epstein-Barr virus (EBV) shows homology to the UL26 and UL80 genes of herpes simplex virus type 1 (HSV-1) and cytomegalovirus (CMV), respectively. These genes are believed to provide a scaffold protein for the assembly of capsids leading to the formation of infectious viral particles. We have cloned the BVRF2 gene from the B95.8 strain of EBV and shown that the BVRF2 gene product is a polyprotein capable of autoproteolytic cleavage. Two Ala-Ser-containing recognition sequences were identified in the BVRF2 polyprotein at amino acid positions 568/569 and 570/571 where this cleavage was expected to occur. Here, we show that EBV proteinase is capable of cleaving at the first Ala-Ser bond but not the second. Comparison of the processing of the EBV and human CMV assembly domains in vitro by either EBV or human CMV proteinase revealed that, while both proteinases could cleave their native assembly domain, only EBV proteinase was able to cleave the assembly domain of the other virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815503      PMCID: PMC188701     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

2.  The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth.

Authors:  M Gao; L Matusick-Kumar; W Hurlburt; S F DiTusa; W W Newcomb; J C Brown; P J McCann; I Deckman; R J Colonno
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  Investigation of the specificity of the herpes simplex virus type 1 protease by point mutagenesis of the autoproteolysis sites.

Authors:  P J McCann; D R O'Boyle; I C Deckman
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

Review 4.  The B cell-immortalizing functions of Epstein-Barr virus.

Authors:  C J Ring
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

5.  Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA.

Authors:  V G Preston; J A Coates; F J Rixon
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

6.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.

Authors:  C Debouck; J G Gorniak; J E Strickler; T D Meek; B W Metcalf; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  In vivo half-life of a protein is a function of its amino-terminal residue.

Authors:  A Bachmair; D Finley; A Varshavsky
Journal:  Science       Date:  1986-10-10       Impact factor: 47.728

8.  Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine.

Authors:  A R Welch; L M McNally; M R Hall; W Gibson
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain.

Authors:  R Jupp; S Hoffmann; R M Stenberg; J A Nelson; P Ghazal
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box.

Authors:  R Jupp; S Hoffmann; A Depto; R M Stenberg; P Ghazal; J A Nelson
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more
  12 in total

1.  The amino-conserved domain of human cytomegalovirus UL80a proteins is required for key interactions during early stages of capsid formation and virus production.

Authors:  Amy N Loveland; Nang L Nguyen; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

2.  Substrate modulation of enzyme activity in the herpesvirus protease family.

Authors:  Ana Lazic; David H Goetz; Anson M Nomura; Alan B Marnett; Charles S Craik
Journal:  J Mol Biol       Date:  2007-08-16       Impact factor: 5.469

3.  Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.

Authors:  Wen-Hung Wang; Chung-Wen Kuo; Li-Kwan Chang; Chen-Chia Hung; Tzu-Hsuan Chang; Shih-Tung Liu
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

4.  Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.

Authors:  Nina Orlova; Mark H Fogg; Angela Carville; Fred Wang
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

5.  Sequential autoprocessing of Marek's disease herpesvirus protease differs from that of other herpesviruses.

Authors:  S Laurent; C Blondeau; M Belghazi; S Remy; E Esnault; P Rasschaert; D Rasschaert
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  Virus-specific interaction between the human cytomegalovirus major capsid protein and the C terminus of the assembly protein precursor.

Authors:  M Beaudet-Miller; R Zhang; J Durkin; W Gibson; A D Kwong; Z Hong
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Identification of a minimal hydrophobic domain in the herpes simplex virus type 1 scaffolding protein which is required for interaction with the major capsid protein.

Authors:  Z Hong; M Beaudet-Miller; J Durkin; R Zhang; A D Kwong
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics.

Authors:  R L LaFemina; K Bakshi; W J Long; B Pramanik; C A Veloski; B S Wolanski; A I Marcy; D J Hazuda
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Cloning, expression and characterization of the proteinase from human herpesvirus 6.

Authors:  N J Tigue; P J Matharu; N A Roberts; J S Mills; J Kay; R Jupp
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Self-assembly of Epstein-Barr virus capsids.

Authors:  Brandon W Henson; Edward M Perkins; Jonathan E Cothran; Prashant Desai
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.